Daniel J. O’Connor is a 25+ year biotech executive specializing in oncology drug development and corporate turnarounds. As CEO of companies like Jubilant Therapeutics and Ambrx, he has a record of scaling clinical-stage enterprises, highlighted by the $2 billion acquisition of Ambrx under his leadership. He holds a J. D. from Penn State Dickinson Law.
Outside of his corporate roles, Daniel is a U. S. Marine Corps veteran who served as a Captain during Operation Desert Shield. A second-generation Irish American, he values home and family, is married with three sons, and mentions enjoying a cold beer at the end of the day.
Unique fact: Before his career in biotech, he served as a criminal prosecutor in Somerset County, New Jersey.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.